Implementation of cytokines to optimize cancer treatment outcomes.
Smith
Judith A
JA
Department of Gynecologic Oncology, Division of Surgery, The University of Texas M. D. Anderson Cancer Center, PO. Box 301439 Unit 1362, Houston, TX 77230-1439, USA. jasmith@mdanderson.org
D000740:Anemia / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control; D000970:Antineoplastic Agents / Q000009:adverse effects; D016207:Cytokines / Q000627:therapeutic use*; D006801:Humans; D052016:Mucositis / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control; D009369:Neoplasms / Q000188:drug therapy*; D009503:Neutropenia / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control; D013921:Thrombocytopenia / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D016207:Cytokines